Valvular heart disease: a primer for the clinical pharmacist. - Wikidata - wikimedia - TriplyDB

Valvular heart disease: a primer for the clinical pharmacist.

Valvular heart disease: a primer for the clinical pharmacist.

http://www.wikidata.org/entity/Q37823573

about

Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review Evolvement of a warfarin medication therapy adherence clinic in Malaysia and its impact on international normalised ratio control over time

P2860

Q28071807-A43AAA42-C5A1-4B02-ACBF-DC26B025950D Q57928331-B1FA6108-5E40-4AC5-8A27-8895C70053CE

P2860

Valvular heart disease: a primer for the clinical pharmacist.

http://www.wikidata.org/entity/Q37823573

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Valvular heart disease: a primer for the clinical pharmacist.

@en

Valvular heart disease: a primer for the clinical pharmacist.

@nl

type

label

Valvular heart disease: a primer for the clinical pharmacist.

@en

Valvular heart disease: a primer for the clinical pharmacist.

@nl

prefLabel

Valvular heart disease: a primer for the clinical pharmacist.

@en

Valvular heart disease: a primer for the clinical pharmacist.

@nl

P1433

Q37823573-91B4AD15-5A68-46D2-BE1F-66CBA5370D0F

P1476

Q37823573-CA7DFF03-9245-41CF-A845-DFBA97B02679

P2093

Q37823573-88B14C18-B486-4B97-8E20-09CAF702BE90

Q37823573-F01D9AB9-1119-40F3-9C5C-213598F4D0E6

P2860

Q37823573-1025F3C5-94CA-4717-8A90-AA08D2CCAB3A

Q37823573-12168F40-EF30-4898-85D6-183A69ABF698

Q37823573-21302F86-7E5C-46E4-AFE8-33A150A1D86A

Q37823573-29F28ADA-7149-4B17-A2CF-9E7E4605F6D2

Q37823573-2ADFC857-4182-4F81-9961-651E9A01B925

Q37823573-51926053-B7A5-4EDF-8674-9757BDF7FE84

Q37823573-5B4FE904-DF0A-4021-95FD-94ABB0ED38A1

Q37823573-5CFC0E1E-D0A5-48A0-9E43-C71E1328034F

Q37823573-5FC005D5-2A50-41C9-8951-0654954323F4

Q37823573-68F1F966-1A6C-424F-B439-960E432E3064

P304

Q37823573-8995C34B-DB24-414B-8E93-E630459871A0

P31

Q37823573-A9EEBBA8-434F-4578-872F-549D8B5917AF

Q37823573-b85bd255-eadd-4618-aa30-17cfba1242fe

P356

Q37823573-FE0B7552-A8E9-4711-ABFE-8082E5449BB6

P407

Q37823573-E74DE5D1-29D5-4E1C-A566-D5DBC8CD426F

P433

Q37823573-D8261CDD-1E53-49AC-AB39-C2D73CEE8016

P478

Q37823573-CD4EFD87-8827-4EFF-8CD5-96844CE8694F

P577

Q37823573-114DB230-2358-432D-8984-EBE1AC9E000C

P698

Q37823573-28CFF884-3C42-42B2-B220-3926EF693189

P356

P1433

Pharmacotherapy

P1476

Valvular heart disease: a primer for the clinical pharmacist.

@en

P2093

Brian Sonnenberg

http://www.w3.org/2001/XMLSchema#string

Tammy J Bungard

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Dronedarone for atrial fibrillation--an odyssey

Is mitral valve repair superior to replacement in elderly patients?

Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).

Aortic stenosis.

Management of patients with prosthetic heart valves: potential impact of valve site, clinical characteristics, and comorbidity.

Modern management of mitral stenosis.

Amiodarone versus sotalol for atrial fibrillation.

Pathogenesis of group A streptococcal infections and their sequelae.

Role of MRI in clinical cardiology.

P304

76-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.31.1.76

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21182361

http://www.w3.org/2001/XMLSchema#string